Summary
In this article, published by the Harm & Evidence Research Collaborative, Sharon Hartles examines the UK Government’s response in relation to the implementation of the recommendations set out in the Independent Medicines and Medical Devices Safety Review, First Do No Harm report. She explores how the Government’s response has impacted on those harmed by the side effects of Primodos, Mesh and Sodium Valproate.
Content
Read the full article: Primodos, Mesh and Sodium Valproate: Recommendations and the UK Government’s response
Other articles by this author:
- Primodos: The next steps towards justice (November 2020)
- Sodium Valproate: The Fetal Valproate Syndrome Tragedy
- Mesh: Denial, half-truths and the harms (March 2021)
Related reading:
- A year on from the Cumberlege Review: Initial reflections on the Government’s response (Patient Safety Learning, 23 July 2021)
- Government response to the report of the Independent Medicines and Medical Devices Safety Review (21 July 2021)
- Independent Report of the Patient Reference Group – response to the report of the Independent Medicines and Medical Devices Safety Review (21 July 2021)
- Regulatory flaws: Women were catastrophically failed in the mesh, Primodos and Sodium Valproate tragedies
Primodos, mesh and sodium valproate: Recommendations and the UK Government’s response (Sharon Hartles, August 2021)
https://www.open.ac.uk/researchcentres/herc/blog/primodos-mesh-and-sodium-valproate-recommendations-and-uk-government%E2%80%99s-response
0
reactions so far
0 Comments
Recommended Comments
There are no comments to display.
Create an account or sign in to comment
You need to be a member in order to leave a comment
Create an account
Sign up for a new account in our community. It's easy!
Register a new accountSign in
Already have an account? Sign in here.
Sign In Now